Bio Products wishes to contract out the conduct of a multicentre safety and efficacy study if an Intravenous Immunoglobulin in patients with Idiopathic Thrombocytopenic Purpura (ITP). The study is to be conducted in Europe and Russia- To include study management, analysis and reporting.